Xeris Biopharma Holdings Inc.

Last updated September 27, 2026

Organization details

Legal name
Xeris Biopharma Holdings Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Headquarters city
Chicago
Headquarters state / province
Illinois
Headquarters country
United States
Fiscal year end
December
Ticker symbol
XERS
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001867096
EIN
87-1082097

Board of directors

Director election results

Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

7 of this board's directors also sit on 13 other boards. 12 are in the same sector.

Network of Xeris Biopharma Holdings Inc.'s board connections AnaptysBio Inc. AnaptysBio Inc. Axogen Inc. Axogen Inc. BioLineRx Ltd. BioLineRx Ltd. BlossomHill Therapeutics Inc. BlossomHill Therapeuti... BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology The... Design Therapeutics Inc. Design Therapeutics In... First Tracks Biotherapeutics Inc. First Tracks Biotherap... Helix Acquisition Corp. III Helix Acquisition Corp... Labcorp Holdings Inc. Labcorp Holdings Inc. Larimar Therapeutics Inc. Larimar Therapeutics I... Rezolute Inc. Rezolute Inc. Verastem Inc. Verastem Inc. Vistagen Therapeutics Inc. Vistagen Therapeutics... Barbara-Jean Anne Bormann-Kennedy Barbara-Jean Anne Bo... Garheng Kong Garheng Kong Jeffrey W. Sherman Jeffrey W. Sherman John Johnson John Johnson John P. Schmid John P. Schmid Nerissa Kreher Nerissa Kreher Paul R. Edick Paul R. Edick Xeris Biopharma Holdings I...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$5,830,808
35 sales by 9 insiders
Date Insider Transaction Shares Price Value
Nov 5, 2026 McCulloch Kevin Officer (See Remarks) Open-market sale −25,000 $12.49 $312,215
Nov 2, 2026 Hecht Beth Officer (See Remarks) Open-market sale −25,000 $10.23 $255,828
Nov 2, 2026 McCulloch Kevin Officer (See Remarks) Open-market sale −15,000 $10.23 $153,488
Nov 2, 2026 Pieper Steven Officer (See Remarks) Open-market sale −5,000 $10.23 $51,174
Nov 2, 2026 Menassie Taddese Director Grant or award +22,365 — —
Oct 1, 2026 Hecht Beth Officer (See Remarks) Open-market sale −16,666 $9.41 $156,792
Oct 1, 2026 McCulloch Kevin Officer (See Remarks) Open-market sale −15,000 $9.41 $141,120
Oct 1, 2026 Pieper Steven Officer (See Remarks) Open-market sale −5,000 $9.41 $47,037
Sep 28, 2026 McCulloch Kevin Officer (See Remarks) Open-market sale −25,000 $10.00 $250,000
Sep 1, 2026 Hecht Beth Officer (See Remarks) Open-market sale −16,666 $8.49 $141,494
Sep 1, 2026 McCulloch Kevin Officer (See Remarks) Open-market sale −15,000 $8.49 $127,350
Sep 1, 2026 Pieper Steven Officer (See Remarks) Open-market sale −5,000 $8.50 $42,500
Aug 12, 2026 Pieper Steven Officer (See Remarks) Open-market sale −5,000 $8.50 $42,500
Aug 3, 2026 Hecht Beth Officer (See Remarks) Open-market sale −16,666 $8.01 $133,495
Aug 3, 2026 McCulloch Kevin Officer (See Remarks) Open-market sale −15,000 $8.02 $120,300

Organizations in the same sector, closest in location and size first.

Questions about Xeris Biopharma Holdings Inc.

How many directors are on Xeris Biopharma Holdings Inc.'s board?

Xeris Biopharma Holdings Inc.'s board has 13 directors: Barbara-Jean Anne Bormann-Kennedy, Dawn Halkuff, Garheng Kong, James Aloysius Brady, Jeffrey W. Sherman, John Johnson, John P. Schmid, John Patrick Shannon Jr., Marla Persky, Menassie Taddese and 3 others.

Are Xeris Biopharma Holdings Inc. insiders buying or selling shares?

Over the last 12 months, Xeris Biopharma Holdings Inc. insiders made no open-market purchases and sold $5.8 million of shares in 35 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="xeris-biopharma-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.